Literature DB >> 24480320

Membrane rafts as a novel target in cancer therapy.

Anita Hryniewicz-Jankowska1, Katarzyna Augoff2, Agnieszka Biernatowska1, Joanna Podkalicka1, Aleksander F Sikorski3.   

Abstract

Membrane rafts are distinct plasma membrane microdomains that are enriched in sphingolipids and cholesterol. They organize receptors and their downstream molecules and regulate a number of intracellular signaling pathways. This review presents information on the dependence of several growth factor receptor signaling pathways on membrane rafts. It also discusses the involvement of rafts in the regulation of differentiation, apoptosis and cell migration connected with invasiveness and metastasis. Examples of known synthetic and naturally occurring substances that are known to affect lateral membrane organization in tumor cell growth are discussed as potential or actual therapeutics.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cancer therapy; Cholesterol; Growth factor receptor signaling; Membrane rafts; Neoplasia

Mesh:

Year:  2014        PMID: 24480320     DOI: 10.1016/j.bbcan.2014.01.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  24 in total

Review 1.  Omega-3 fatty acids, membrane remodeling and cancer prevention.

Authors:  Natividad R Fuentes; Eunjoo Kim; Yang-Yi Fan; Robert S Chapkin
Journal:  Mol Aspects Med       Date:  2018-04-12

Review 2.  Emerging role of chemoprotective agents in the dynamic shaping of plasma membrane organization.

Authors:  Natividad R Fuentes; Michael L Salinas; Eunjoo Kim; Robert S Chapkin
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-03-22       Impact factor: 3.747

3.  The role of cholesterol and cholesterol-driven membrane raft domains in prostate cancer.

Authors:  Anita Hryniewicz-Jankowska; Katarzyna Augoff; Aleksander F Sikorski
Journal:  Exp Biol Med (Maywood)       Date:  2019-10

Review 4.  Cell membrane modulation as adjuvant in cancer therapy.

Authors:  Sara Zalba; Timo L M Ten Hagen
Journal:  Cancer Treat Rev       Date:  2016-11-09       Impact factor: 12.111

5.  Diet-induced hypercholesterolemia promotes androgen-independent prostate cancer metastasis via IQGAP1 and caveolin-1.

Authors:  Hyeongsun Moon; Jayde E Ruelcke; Eunju Choi; Laura J Sharpe; Zeyad D Nassar; Helle Bielefeldt-Ohmann; Marie-Odile Parat; Anup Shah; Mathias Francois; Kerry L Inder; Andrew J Brown; Pamela J Russell; Robert G Parton; Michelle M Hill
Journal:  Oncotarget       Date:  2015-04-10

6.  Different associations of CD45 isoforms with STAT3, PKC and ERK regulate IL-6-induced proliferation in myeloma.

Authors:  Xu Zheng; Allison S Li; Huanyu Zheng; Dongmei Zhao; Dagang Guan; Huawei Zou
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

7.  Flotillin-2 promotes metastasis of nasopharyngeal carcinoma by activating NF-κB and PI3K/Akt3 signaling pathways.

Authors:  Jie Liu; Wei Huang; Caiping Ren; Qiuyuan Wen; Weidong Liu; Xuyu Yang; Lei Wang; Bin Zhu; Liang Zeng; Xiangling Feng; Chang Zhang; Huan Chen; Wei Jia; Lihua Zhang; Xiaomeng Xia; Yuxiang Chen
Journal:  Sci Rep       Date:  2015-07-24       Impact factor: 4.379

8.  Molecular characterization of direct interactions between MPP1 and flotillins.

Authors:  Agnieszka Biernatowska; Paulina Olszewska; Krzysztof Grzymajło; Dominik Drabik; Sebastian Kraszewski; Aleksander F Sikorski; Aleksander Czogalla
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

Review 9.  Lipid Raft-Mediated Regulation of Hyaluronan-CD44 Interactions in Inflammation and Cancer.

Authors:  Toshiyuki Murai
Journal:  Front Immunol       Date:  2015-08-20       Impact factor: 7.561

10.  TNF-α promotes breast cancer cell migration and enhances the concentration of membrane-associated proteases in lipid rafts.

Authors:  Dominika Wolczyk; Magdalena Zaremba-Czogalla; Anita Hryniewicz-Jankowska; Renata Tabola; Krzysztof Grabowski; Aleksander F Sikorski; Katarzyna Augoff
Journal:  Cell Oncol (Dordr)       Date:  2016-04-04       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.